Natixis Advisors LLC lessened its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 3.9% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,627,307 shares of the company's stock after selling 66,907 shares during the period. Natixis Advisors LLC owned approximately 0.24% of Corteva worth $95,670,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the company. KBC Group NV boosted its position in Corteva by 267.3% during the third quarter. KBC Group NV now owns 1,120,104 shares of the company's stock valued at $65,851,000 after buying an additional 815,135 shares during the period. Intech Investment Management LLC grew its position in shares of Corteva by 69.5% during the 1st quarter. Intech Investment Management LLC now owns 52,557 shares of the company's stock valued at $3,031,000 after acquiring an additional 21,545 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in shares of Corteva by 51.4% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 123,621 shares of the company's stock valued at $6,668,000 after acquiring an additional 41,943 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Corteva by 0.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 220,134 shares of the company's stock worth $12,942,000 after buying an additional 845 shares during the period. Finally, Anomaly Capital Management LP bought a new position in shares of Corteva during the 2nd quarter valued at about $188,578,000. Hedge funds and other institutional investors own 81.54% of the company's stock.
Corteva Stock Down 3.8 %
CTVA stock traded down $2.20 during mid-day trading on Friday, hitting $55.21. The stock had a trading volume of 5,636,720 shares, compared to its average volume of 3,186,660. The company has a current ratio of 1.50, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $37.95 billion, a price-to-earnings ratio of 55.77, a PEG ratio of 1.77 and a beta of 0.77. The company has a fifty day moving average of $58.34 and a 200 day moving average of $55.67. Corteva, Inc. has a 1-year low of $43.89 and a 1-year high of $63.75.
Corteva Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Monday, December 2nd. This represents a $0.68 annualized dividend and a yield of 1.23%. Corteva's payout ratio is 68.69%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on CTVA shares. Citigroup initiated coverage on shares of Corteva in a research report on Wednesday, October 23rd. They set a "buy" rating and a $68.00 target price on the stock. Oppenheimer restated an "outperform" rating and issued a $70.00 target price (up from $69.00) on shares of Corteva in a research note on Friday, November 8th. Barclays increased their price objective on shares of Corteva from $58.00 to $62.00 and gave the company an "equal weight" rating in a research note on Friday, November 8th. UBS Group raised their target price on shares of Corteva from $67.00 to $71.00 and gave the company a "buy" rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Corteva from $57.00 to $55.00 and set a "neutral" rating for the company in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $63.68.
Get Our Latest Stock Analysis on Corteva
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Articles
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.